Narrative review explores monocyte roles in tumor development, progression, and immunotherapy.

This publication is a narrative review that synthesizes existing literature on monocytes in the context of oncology. Its scope covers the roles of monocytes in tumor development and progression within the tumor microenvironment, as well as their potential applications in cancer immunotherapy, specifically monocyte-mediated vaccines and combination therapies with immune checkpoint inhibitors. The review does not report specific study populations, sample sizes, interventions, comparators, primary or secondary outcomes, follow-up durations, or quantitative results such as effect sizes or p-values, as it is not a meta-analysis or primary trial.

The authors present qualitative conclusions based on the reviewed literature, highlighting the involvement of monocytes in tumor processes and their emerging therapeutic potential. However, no pooled data, numerical findings, or detailed clinical outcomes are provided, reflecting the narrative nature of the review. Limitations are not explicitly noted in the input, but the absence of systematic methods or quantitative synthesis suggests inherent gaps in evidence strength and comprehensiveness.

In terms of practice relevance, the review offers conceptual insights rather than actionable clinical guidance. It underscores the need for further research to validate these approaches, as the evidence remains early and theoretical. Clinicians should interpret the findings cautiously, recognizing that they are derived from a non-systematic synthesis without specific safety data or efficacy metrics reported.